ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Percheron Therapeutics Ltd

Percheron Therapeutics Ltd (PER)

0.003
-0.001
( -25.00% )
更新日時: 09:14:59

Percheron Therapeutics Ltd (PER) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.003
( -25.00% )
買値
0.003
売値
0.004
出来高
22,368,469
0.003 日の範囲 0.004
0.003 52 週間の範囲 0.013
時価総額
前日終値
0.004
始値
0.004
最終取引時間
12:56:42
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 2,647,323
発行済株式数
1,522,412,686
配当利回り
PER
-0.46
1 株当たり利益 (EPS)
-0.01
歳入
1.74M
純利益
-9.49M

Percheron Therapeutics Ltd について

Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenn... Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company’s lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Melbourne, Australia
設立
2026
Percheron Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker PER. The last closing price for Percheron Therapeutics was AUD0. Over the last year, Percheron Therapeutics shares have traded in a share price range of AUD 0.003 to AUD 0.013.

Percheron Therapeutics currently has 1,522,412,686 shares in issue. The market capitalisation of Percheron Therapeutics is AUD4.57 million. Percheron Therapeutics has a price to earnings ratio (PE ratio) of -0.46.

PER 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.001-250.0040.0050.00375492290.00392346DE
4-0.002-400.0050.0050.00332299230.00407142DE
12-0.003-500.0060.0060.00332691830.00451214DE
26-0.006-66.66666666670.0090.010.00320104360.00510386DE
52-0.006-66.66666666670.0090.0130.00318673940.00715749DE
156-0.055-94.82758620690.0580.140.00331453840.0216227DE
260-0.055-94.82758620690.0580.140.00331453840.0216227DE

PER - Frequently Asked Questions (FAQ)

What is the current Percheron Therapeutics Ltd share price?
The current share price of Percheron Therapeutics Ltd is AUD 0.003
How many Percheron Therapeutics Ltd shares are in issue?
Percheron Therapeutics Ltd has 1,522,412,686 shares in issue
What is the market cap of Percheron Therapeutics Ltd?
The market capitalisation of Percheron Therapeutics Ltd is AUD 4.57M
What is the 1 year trading range for Percheron Therapeutics Ltd share price?
Percheron Therapeutics Ltd has traded in the range of AUD 0.003 to AUD 0.013 during the past year
What is the PE ratio of Percheron Therapeutics Ltd?
The price to earnings ratio of Percheron Therapeutics Ltd is -0.46
What is the cash to sales ratio of Percheron Therapeutics Ltd?
The cash to sales ratio of Percheron Therapeutics Ltd is 3.5
What is the registered address of Percheron Therapeutics Ltd?
The registered address for Percheron Therapeutics Ltd is Collins Place, Melbourne, Victoria, 3000
What is the Percheron Therapeutics Ltd website address?
The website address for Percheron Therapeutics Ltd is percherontx.com
Which industry sector does Percheron Therapeutics Ltd operate in?
Percheron Therapeutics Ltd operates in the Pharmaceuticals sector

PER 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄